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Introduction
Antibodies specific for native human type II collagen
(anti-CII) characterize an early inflammatory/destructive
phenotype in adults with RA. There are no data pre-
sented so far on this antibody and its possible influence
on disease course/outcome in children with JIA.
Objectives
We wanted to relate occurrence of anti-CII, IgM-RF,
IgA-RF and anti-CCP to assessment of joint damage,
outcome and ILAR categories after eight years of disease
in children with JIA.
Methods
From the Nordic JIA database 192 patients with available
sera were included. Serum samples were collected at a
median time of 4 months (IQR 2-7) after disease onset.
Patients were followed prospectively for a median of 97
months (IQR 95-105). At the 8-year follow-up visit, data
on remission according to the preliminary criteria of C.
Wallace et al as well as joint damage according to JADI
were collected. Frozen and stored sera were analyzed
with enzyme immunoassays for anti-CII, IgM-RF, IgA-RF
and anti-CCP. Reference values for adults were used.
Results
Anti-type II collagen antibodies occurred in 3.1% of patients
sera, IgM-RF in 3.6%, IgA-RF in 3.1%, anti-CCP in 2.6% of
the patients. Occurrence of RF and anti-CCP did to some
extent overlap, but rarely with anti-CII. The polyarticular
and oligoarticular extended categories were overrepresented
in patients with any of the four autoantibodies. All four
autoantibodies were significantly associated with joint
damage after eight years, but we found no association with
ongoing disease activity after eight years.
Conclusion
- Occurrence of anti-CII did rarely overlap with anti-
CCP, IgA-RF and IgM-RF, but all four were asso-
ciated with joint damage after 8 years of disease in
patients with JIA.
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